Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-19-024666
Filing Date
2019-10-02
Accepted
2019-10-02 16:15:52
Documents
1
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3635
  Complete submission text file 0000899243-19-024666.txt   4975
Mailing Address 441 CHARMANY DRIVE MADISON WI 53719
Business Address
Conroy Kevin T (Reporting) CIK: 0001306119 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35945 | Film No.: 191132409

Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Issuer) CIK: 0001571498 (see all company filings)

EIN.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations